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Case report
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SummAry
Perivascular epithelioid cell neoplasms are a group of rare tumours reported in various organs under a variety of designations. Such tumours 
are of interest primarily because of the distinctive morphology of their cell population and their immunoreactivity with melanocytic and 
myoid markers. There is a strong association between perivascular epithelioid cell neoplasms and tuberous sclerosis complex. Perivascular 
epithelioid cell neoplasms very rarely occur in the upper aero-digestive tract. To date only three cases of nasal perivascular epithelioid cell 
neoplasms have been reported in the literature. The present report refers to a 22-year old woman, without any stigmata of tuberous sclerosis 
complex, with early onset of a polypoid nasal mass with pathological and immunohistochemical features entirely compatible with those of 
a perivascular epithelioid cell neoplasm.
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riASSunTo
Le neoplasie a cellule epitelioidi perivascolari sono un gruppo di tumori rari che possono coinvolgere diversi organi. Questi tumori sono 
di particolare interesse per la peculiare morfologia delle cellule neoplastiche e per la loro immunoreattività per marcatori melanocitari e 
mioidi. È stata dimostrata una chiara associazione fra le neoplasie a cellule epitelioidi perivascolari e la sclerosi tuberosa. Le neoplasie 
a cellule epitelioidi perivascolari molto raramente si manifestano nelle vie superiori. Al momento sono stati riportati solo tre casi di neo-
plasia a cellule epitelioidi perivascolari a livello nasale. Nel presente lavoro presentiamo un caso di neoplasia nasale a cellule epitelioidi 
perivascolari non associata a sclerosi tuberosa.
PArole ChiAve: Neoplasia a cellule epitelioidi perivascolari • Immunoistochimica • Cavità nasale • Sclerosi tuberosa • Malattia rara
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Introduction
Perivascular  epithelioid  cell  neoplasms  (PeComas)  are 
a group of rare mesenchymal tumours sharing unusual 
histological,  immunohistochemical  and  ultrastructural 
features 1. Such tumours are composed of a distinctive 
cell population defined as perivascular epithelioid cells 
(PeCs), characterized by acidophilic or clear cytoplasm, 
which typically coexpress smooth muscle and melano-
genesis markers 1. The PeComa family includes different 
entities, reported in different organs and include angiomy-
olipoma (Aml), clear-cell “sugar” tumour of the lung 
(CCST), lymphangioleiomyomatosis (lAm), and other 
more uncommon clear cell tumours arising at a variety 
of visceral, bone and soft tissue sites, such as the clear 
cell myomelanocytic tumour of the falciform ligament/
ligamentum teres 1.
Aml and lAm are strictly associated to tuberous sclero-
sis complex (TSC) 1. TSC (omim 191100) is an autosom-
al dominant inherited condition characterized by hamar-
tomas in the brain, skin, eyes, heart, lungs and kidneys. 
moreover, epilepsy, mental retardation and autism are of-
ten present. The disorder is caused by inactivating muta-
tions in either the TSC1 (9q34) or TSC2 (16p13.3) genes 
which seem to play a role in the regulation of the rheb/
mTor/p70S6K pathway. Activation of this pathway has early onset of a nasal perivascular epithelioid cell neoplasm not related to tuberous sclerosis complex
199
been observed both in TSC-related and non-TSC-related 
PeComas 1.
generally,  PeComas  are  considered  benign  tumours, 
however, in some cases, a malignant potential has also 
been observed 1. The mainstay of treatment is wide ex-
cision although some current clinical trials are examin-
ing the benefit of mTorC1 inhibitors, such as rapamy-
cin 2-4.
PeComas are rare tumours and their occurrence in the 
upper aero-digestive tract is even more rare. in fact, a 
thorough search on several databases disclosed that, to 
date, only three cases of PeComa, arising in the nasal 
cavity, have been reported 3-5. herewith a fourth case is 
reported with early onset, histological features of splind-
ed clear cell tumour and typical immunohistochemical 
features.
Case report
The patient, a 22-year-old female, was born to unrelated 
parents after 3 spontaneous abortions by the mother. Preg-
nancy and delivery were uneventful and the infant’s psy-
chomotor development was normal. There was no family 
history of TSC, hamartomas or epilepsy. her parents suf-
fered from renal calculosis.
The patient’s clinical history was otherwise unremarkable 
until the age of 22 years when she presented epistaxis 
and respiratory difficulties due to a left nasal obstruction. 
Clinical otorhinolaryngologic examination, computed to-
mography (CT) and magnetic resonance imaging (mri) 
scans revealed a left nasal polypoid mass, 1.5 cm in di-
ameter, with deviation of the septum to the right (Fig. 1). 
Therefore, an endoscopic anterior turbinectomy with a 
diode laser was performed, permitting en-bloc removal 
of the tumour; the post-operative course was uneventful. 
histological examination showed proliferation of epithe-
lioid or spindled cells with wide, clear or eosinophilic cy-
toplasm, organized in large bundles around ectatic blood 
vessels. neoplastic cells showed mild atypia (oval nuclei 
and small nucleoli). There was no significant mitosis or 
necrosis. The immunohistochemical study demonstrated 
coexpression of myogenic and melanocytic markers such 
as  actin,  muscle  actin,  desmin,  melan A,  and  hmB45 
(Fig. 2). Progesterone receptor expression was observed 
in a limited number of nuclei (Fig. 2). immunoreactions 
for cytokeratins, emA, vimentin, myogenin, S100 pro-
tein, Cd56/n-CAm, Cd10, oestrogen receptor and Cd34 
gave negative results. The histological and immunohis-
tochemical features were consistent with a diagnosis of 
PeComa 1.
At  clinical  re-evaluation,  the  patient  presented  no 
clinical findings suggestive of TSC: skin examination 
revealed only one hypopigmented macula on the left 
thigh and two cafè-au-lait spots > 1.5 cm in diameter 
on the left thigh and the right thigh, respectively, no 
other cutaneous signs of TSC were observed. Finally, it 
should also be pointed out that ophthalmologic assess-
ment, cardiological evaluation, including echocardio-
Fig. 2. A. Low power view of surgical sample from the polypoid endo-nasal 
mass. On haematoxylin-eosin stain, clear cells are organized in nests with 
interposed connective stroma. Respiratory epithelium covers surface of le-
sion (10x). B. Immunohistochemical reaction with antibodies directed against 
muscle actin staining diffusely PEComa cells (20x). C. Immunohistochemi-
cal reaction with antibodies directed against progesterone receptor staining 
only part of the nuclei in the lesion (40x). D. Immunohistochemical reaction 
with antibodies directed against HMB45 staining the cytoplasm of sparse 
PEComa cells (40x).
Fig. 1. A. Coronal CT image. Polypoid formation (star) occupying anterior 
part of left nasal fossae and inferior meatous, reaching cranially the ante-
rior margin of the middle turbinate (horizontal arrow). There are no signs 
of infiltration or bony destruction but a nasal septum deviation (vertical 
arrow). B. Coronal T1 (post-contrast) MRI. The mass (star) shows a ho-
mogeneous signal after gadolinium administration. The bony framework 
and septal cartilage show no signs of infiltration. C. Sagittal CT image. 
Evaluation of both sagittal and antero-posterior extension of the polypoid 
formation (star) with preservation of bony framework. D. Sagittal T1 (post-
contrast) MRI. Homogeneous signal of the polyp (star) following gadolinium 
administration.S. gana et al.
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gram, abdomen and renal ultrasound, and brain mri, 
were normal.
The patient underwent a further endonasal surgery for the 
removal of residual neoplastic tissue one month after the 
first polypectomy. recurrence of the nasal lesion has not 
been observed over a 13-month follow-up.
Discussion
in this report, a PeComa is described occurring in the 
upper respiratory tract presenting as an endo-nasal poly-
poid mass.
PeComas of the nasal cavity are extremely rare and a 
total of four cases (including the present case) have been 
reported in the literature to date, all in females 3-5. The 
age of the three previously reported cases ranged from 
34 to 79 years, with a mean age 54.3 years. The age of 
our patient (22 years) was younger than in the previously 
reported cases, and also younger than the median age 
recorded  for  visceral  and  mucocutaneous  PeComas 1. 
The left nasal cavity was involved in 3 cases, and the 
nasal septum in one case. All the cases were histologi-
cally benign and presented slight differences in terms 
of immuno-staining for melanocytic and muscular mark-
ers. Concerning follow-up, in one case no recurrence 
was observed after long-term follow-up 5, while in the 
remaining 3 cases the clinical follow-up was too short 
for  evaluation.  Progesterone  receptor  expression  (ob-
served in our case), although limited, is an unusual find-
ing in extra-renal PeComas and to our knowledge has 
never been reported in a nasal lesion 1. The young age 
and the sex of the patient could account for this unusual 
feature.
in the whole PeComa family, Aml and lAm are more 
strongly associated with the tuberous sclerosis complex 
(TSC).  Approximately  60-80%  of  adult  TSC  patients 
present Aml and 25-40% of adult female TSC patients 
present lAm. Conversely, about 80% of patients with 
Aml do not have TSC. other PeComas, although very 
rare and with a less strong association with TSC, however 
occur at a much higher frequency in patients with TSC 
than in the general population 1.
none of the patients affected by PeComa of the nasal cav-
ity, reported in the literature, have any stigmata or fam-
ily history of TSC. however, as early onset of tumours 
is often associated with germline mutations, our patient 
was scrupulously evaluated from a clinical point of view 
to verify if any sign of TSC could be observed. She pre-
sented only one hypopigmented macula and two cafe’- 
au-lait spots in the absence of other cutaneous signs of 
TSC. Furthermore, all the other clinical and radiological 
investigations showed negative results. in conclusion, our 
patient did not fit the clinical criteria typical of a clini-
cal diagnosis of TSC, and thus no molecular testing was 
performed.
Clinically, PeComa of the nasal cavity can be mistaken 
for any other benign or malignant primary or metastatic 
exophytic tumour occurring in the region 3, and, in the 
absence of any particular clinical feature, only histo-
logical examination of the tissue removed can provide 
a correct diagnosis. while the distinction from the most 
common inflammatory or Schneiderian nasal polyp is 
straightforward, on routine histological slides, a range 
of neoplastic lesions can be more difficult to differenti-
ate on pure morphological grounds. Frequent clear cell 
features raise the possibility of a clear cell neoplasm, 
including metastatic renal cell carcinoma, adrenocorti-
cal carcinoma, paraganglioma. renal cell carcinoma, in 
particular, frequently localized to the upper aerodiges-
tive tract, needs to be excluded, in older patients. nega-
tive staining for cytokeratins and Cd10 are the key diag-
nostic feature. The immunohistochemical coexpression 
of a muscle marker (such as smooth-muscle actin) with 
hmB45, in combination with negative staining for S100 
protein, allows a malignant melanoma to be excluded, 
which  shows,  however,  greater  cellular  atypia.  other 
important  differential  diagnoses  of  PeComa  include 
smooth-muscle tumours, which are negative for melano-
cytic markers and have a more eosinophilic cytoplasm, 
and angiomyolipomas. The latter have occasionally been 
described in the nasal cavity but seem to differ from the 
classic renal Aml.
Although the number of single case reports and small 
series is rapidly increasing 1, there is no general agree-
ment regarding the cell from which PeComas originate, 
and no normal counterpart has been recognized. The 
presence of PeComas in different areas of the human 
body, although with an increased frequency in the uter-
us/pelvic area, favours a direct or indirect origin from 
ubiquitous cells, such as undifferentiated cells from the 
neural crests, pericytes or mutated precursors of smooth 
muscle cells.
in our opinion, this description of a further case of Pe-
Coma of the nasal cavity is worthwhile, because of the 
rarity of the disorder, and because the present case is 
the first one to be reported in which an early onset was 
discovered. Although nasal PeComa is a very uncom-
mon lesion, it should be considered in the differential 
diagnosis of polypoid nasal masses, especially when 
the  mass  occurs  unilaterally.  To  date,  including  our 
case, a total of four cases have been reported. There-
fore,  further  reports  on  additional  cases  might  help 
to better understand the link between this tumour and 
TSC and to predict the biological behaviour of these 
very rare and distinctive tumours in terms of recurrence 
and malignancy.early onset of a nasal perivascular epithelioid cell neoplasm not related to tuberous sclerosis complex
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